Phase 1 Dose Expansion Initiated for FT819 Off-the-Shelf CAR T-cell Product Candidate with Fludarabine-free Conditioning in Moderate-to-Severe ...

A new research paper titled "ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells" has been published in Oncotarget. ABT199 ...

The open-label, Phase 1b/2 clinical trial in Israel investigated intravenous Bis/Clo/Flu (bisantrene, clofarabine, fludarabine) in cohorts of adult patients with R/R AML using a Simon’s 2-stage ...